BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27072230)

  • 1. Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60.
    Pazhang Y; Jaliani HZ; Imani M; Dariushnejad H
    J Cancer Res Ther; 2016; 12(1):155-60. PubMed ID: 27072230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
    Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
    Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells.
    Reis-Silva CSM; Branco PC; Lima K; Silva FL; Moreno PRH; Guallar V; Costa-Lotufo LV; Machado-Neto JA
    Toxicol In Vitro; 2021 Oct; 76():105207. PubMed ID: 34216723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation.
    Hu R; Yang Y; Liu Z; Jiang H; Zhu K; Li J; Xu W
    Tumour Biol; 2015 Feb; 36(2):769-77. PubMed ID: 25293521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.
    Zheng L; Fu Y; Zhuang L; Gai R; Ma J; Lou J; Zhu H; He Q; Yang B
    Int J Cancer; 2014 Oct; 135(7):1721-32. PubMed ID: 24615207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
    Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S
    PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma.
    He D; Xu Q; Yan M; Zhang P; Zhou X; Zhang Z; Duan W; Zhong L; Ye D; Chen W
    BMC Cancer; 2009 Sep; 9():343. PubMed ID: 19778460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embelin induces apoptosis in human glioma cells through inactivating NF-κB.
    Park SY; Lim SL; Jang HJ; Lee JH; Um JY; Kim SH; Ahn KS; Lee SG
    J Pharmacol Sci; 2013; 121(3):192-9. PubMed ID: 23514760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
    Hussain AR; Siraj AK; Ahmed M; Bu R; Pratheeshkumar P; Alrashed AM; Qadri Z; Ajarim D; Al-Dayel F; Beg S; Al-Kuraya KS
    BMC Cancer; 2017 Sep; 17(1):640. PubMed ID: 28893228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embelin induces apoptosis of human gastric carcinoma through inhibition of p38 MAPK and NF-κB signaling pathways.
    Xu CL; Zheng B; Pei JH; Shen SJ; Wang JZ
    Mol Med Rep; 2016 Jul; 14(1):307-12. PubMed ID: 27175982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells.
    Wang DG; Sun YB; Ye F; Li W; Kharbuja P; Gao L; Zhang DY; Suo J
    Mol Cell Biochem; 2014 Jan; 386(1-2):143-52. PubMed ID: 24136460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells.
    Hu R; Zhu K; Li Y; Yao K; Zhang R; Wang H; Yang W; Liu Z
    Med Oncol; 2011 Dec; 28(4):1584-8. PubMed ID: 20625944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Celastrol on growth inhibition of U937 leukemia cells through the regulation of the Notch1/NF-kappaB signaling pathway in vitro.
    Wang XN; Wu Q; Yang X; Zhang LS; Wu YP; Lu C
    Chin J Cancer; 2010 Apr; 29(4):385-90. PubMed ID: 20346213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
    Ahn KS; Sethi G; Aggarwal BB
    Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery.
    Zhou J; Lu X; Tan TZ; Chng WJ
    Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
    Wang X; Wang C; Qin YW; Yan SK; Gao YR
    Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells.
    Xie S; Jiang H; Zhai XW; Wei F; Wang SD; Ding J; Chen Y
    Acta Pharmacol Sin; 2016 Nov; 37(11):1481-1489. PubMed ID: 27569395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
    Qian H; Huang T; Chen Y; Li X; Gong W; Jiang G; Zhang W; Cheng S; Li X; Li P
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S648-S655. PubMed ID: 30249882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.